MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

491473

Report Date :

12.02.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

OPTIMUS DRUGS PRIVATE LIMITED [w.e.f. 10.01.2009]

 

 

Formerly Known As :

SURYA KIRAN LABS PRIVATE LIMITED

 

 

Registered Office :

H.No.4-7-101, Scientist Colony, Nacharam, Hyderabad – 500007, Telangana

Tel. No.:

91-40-40069400

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

02.12.2003

 

 

Com. Reg. No.:

36-042155

 

 

Capital Investment / Paid-up Capital :

INR 76.928 Million

 

 

CIN No.:

[Company Identification No.]

U24239TG2003PTC042155

 

 

IEC No.:

0908003404

 

 

GSTIN No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAHCS8074N

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

The company carrying on the business to  manufacturer and generally deal in all types of chemicals, pharmaceuticals, drugs and intermediaries and to carry on the business of consulting engineers in chemicals, pharmaceuticals, and drug industries. [Registered Activity]

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 1267000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2003 and it is a manufacturer of chemicals, pharmaceuticals drugs and intermediaries.

 

Management has failed to file its latest financials with Government Registry.

 

As per the financials of March 2016, the subject has reported a growth of 72.04% in its revenue as compared to its previous year’s revenue and maintained a fair profit margin of 4.23% under review. 

 

Rating also takes into consideration company’s established track record of business operations marked by sound net worth base along with comfortable debt coverage indicators and decent liquidity position.

 

Further, the company has reported good earnings per share of INR 15.86 against its face value of INR 10.

 

Payments seems to be usually correct.

 

In view of the aforesaid, the company can be considered for business dealings at usual trade terms and conditions.   

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 12.02.2018.

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

LOCATIONS

 

Registered Office/ Factory 1 :

H.No.4-7-101, Scientist Colony, Nacharam, Hyderabad – 500007, Telangana, India

Tel. No.:

91-40-27174651

Fax No.:

Not Available

E-Mail :

info@optimuspharma.com

askrco@yahoo.com

Website :

http://www.optimuspharma.com

Location :

Owned

 

 

Corporate Office 1 / Administrative Office :

1-2-11/1, Above SBI Bank, Street No. 2, Kakatiya Nagar, Habsiguda, Hyderabad - 500007, Telangana, India

Tel. No.:

91-40-40069400

Fax No.:

91-40-40069401

E-Mail.:

info@optimuspharma.net 

Website :

www.optimuspharma.net

Location :

Owned

 

 

Corporate Office 2:

E# 6P, 2nd Floor, Singature Towers, Kothagud Kondpur, Hyderabad - 500084, Telangana, India

 

 

Factory 2 :

Survey No. 239 and 240, Dothigudem (V), Pochampally (M), Nalgonda (District) - 508284, Telangana, India

 

 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Mr. Srinivas Reddy Desi Reddy

Designation :

Managing Director

Address :

H No. 9-119, Flat No. 6, Himayat Nagar, Nacharam, Hyderabad – 500076, Telangana, India

Date of Birth/Age :

19.01.1973

Date of Appointment :

01.04.2017

PAN No.:

AFLPB9675G

DIN No.:

01819852

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24239TG2004PTC044232

OPTIMUS PHARMA PRIVATE LIMITED

21/09/2004

-

U27100WB2008PTC123888

TWINE STEEL PRIVATE LIMITED

17/10/2011

-

U24233TG2012PTC079927

OPTRIX LABORATORIES PRIVATE LIMITED

30/12/2016

-

U24233TG2014PTC094608

OPTIMUS GENERICDRUGS PRIVATE LIMITED

24/06/2014

-

U24100TG2016PTC103138

ORYGAMUS LABORATORIES PRIVATE LIMITED

05/02/2016

-

 

 

Name :

Mr. Triveni Desireddy

Designation :

Director

Address :

H No. 9-119, Street No. 1, Himayat  Nagar, Nahcaram, Hyderabad – 500076, Telangana, India

Date of Appointment :

17.01.2017

DIN No.:

02488436

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24239TG2004PTC044232

OPTIMUS PHARMA PRIVATE LIMITED

21/09/2004

-

U27100WB2008PTC123888

TWINE STEEL PRIVATE LIMITED

17/10/2011

-

U24233TG2012PTC079927

OPTRIX LABORATORIES PRIVATE LIMITED

01/04/2017

-

U24233TG2014PTC094608

OPTIMUS GENERICDRUGS PRIVATE LIMITED

24/06/2014

-

 

 

KEY EXECUTIVES

 

Name :

Ms. Preeti Sharma

Designation :

Company Secretary

Address :

101, Aryamitra Blue Bells, Road No.1, Alkapoor Township, Manikonda Hyderabad – 500089, Telangana, India

Date of Appointment :

01.03.2017

PAN No.:

FMHPS4766K

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2016

 

Note: [SHAREHOLDERS DETAILS FILE ATTACHED]

 

 

AS ON 30.09.2016

 

Equity Share Break up

Percentage

Category

 

 

Promoters – [Individual/Hindu Undivided Family – Indian]

71.91

Public/Other than promoters - [Individual/Hindu Undivided Family – Indian]

28.09

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

The company carrying on the business to  manufacturer and generally deal in all types of chemicals, pharmaceuticals, drugs and intermediaries and to carry on the business of consulting engineers in chemicals, pharmaceuticals, and drug industries. [Registered Activity]

 

 

Products / Services :

ITC Code

Product/ Services Description

30021099

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts)and similar products

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Available

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

Customers :

Reference :

Not Available

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

No. of Employees :

Not Available

 

 

Bankers :

  • Axis Bank Limited, 1st Floor, G. Pullareddy Building6-3-879/B, Green Lands, Begumpet, Hyderabad – 500016, Telangana, India

 

Bank Name

ICICI Bank Limited

Branch

ICICI Bank Tower, Near Chakli Circle, Old Padra Road, Vadodara – 390007, Gujarat, India

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

 

Facilities :

SECURED LOANS

31.03.2016

INR In Million

31.03.2015

INR In Million

LONG TERM BORROWINGS

 

 

Term loans from banks

[Axis Bank: First charge on fixed assets of the company. Reliance capital: first charge

on plant and machinery]

50.884

60.518

Other loans and advances

[hypothecation of respective vehicle]

2.384

2.506

SHORT TERM BORROWINGS

 

 

Working capital loans from banks

[Secured by second pari passu charge on fixed assets, first charge on current assets and further secured by collateral

security and personal guarantees  of directors and relatives]

116.386

83.168

Total

169.654

146.192

 

 

Financial Institution:

Reliance Capital Limited, "H" Block 1st Floor, Dhirubhai Ambani Knowledge City, Koparkhairne, Navi Mumbai – 400710, Maharashtra, India

 

 

Auditors :

 

Name :

S. Kasthuri Rengan and Company

Chartered Accountants

Address :

Flat No. 909 A, 9th Floor, Raghava Ratna Towers, Chirag Ali Lane, ABIDS, Hyderabad – 500001, Telangana, India

PAN No.:

ABVFS0052L

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Other Related Parties:

[Other Related Parties]

  • Optrix Laboratories Private Limited, India

[CIN NO.; U24233TG2012PTC079927]

  • Optimus Pharma Private Limited, India

[CIN NO.: U24239AP2004PTC044232]

 

 


 

CAPITAL STRUCTURE

 

AS ON 30.09.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

INR 10/- each

INR 100.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

7692750

Equity Shares

INR 10/- each

INR 76.928 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

31.03.2014

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

76.928

70.640

58.917

(b) Reserves and Surplus

366.638

210.362

118.173

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

443.566

281.002

177.090

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

70.686

86.541

125.173

(b) Deferred tax liabilities (Net)

7.677

13.186

9.659

(c) Other long-term liabilities

0.000

0.000

25.119

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

78.363

99.727

159.951

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

116.386

83.168

56.358

(b) Trade payables

565.793

390.766

230.211

(c) Other current liabilities

77.344

67.227

30.213

(d) Short-term provisions

0.000

0.000

0.000

Total Current Liabilities (4)

759.523

541.161

316.782

 

 

 

 

TOTAL

1281.452

921.890

653.823

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

372.645

263.582

228.341

(ii) Intangible Assets

0.000

0.245

0.552

(iii) Tangible assets capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

0.000

0.000

0.000

(e) Other Non-current assets

3.202

0.000

0.000

Total Non-Current Assets

375.847

263.827

228.893

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

152.558

60.570

54.132

(c) Trade receivables

322.993

494.258

280.615

(d) Cash and bank balances

254.974

22.640

7.011

(e) Short-term loans and advances

0.000

0.000

83.172

(f) Other current assets

175.080

80.595

0.000

Total Current Assets

905.605

658.063

424.930

 

 

 

 

TOTAL

1281.452

921.890

653.823

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

Total Revenue from operations

2651.244

1541.081

1085.003

 

Other Income

5.413

6.037

0.707

 

TOTAL

2656.657

1547.118

1085.710

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

2255.449

1257.208

931.802

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(97.525)

(0.812)

5.284

 

Employee benefit expense

136.465

98.639

42.784

 

Other expenses

173.718

88.111

33.240

 

TOTAL

2468.107

1443.146

1013.110

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

188.550

103.972

72.600

 

 

 

 

 

Less

FINANCIAL EXPENSES

27.298

16.643

12.877

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

161.252

87.329

59.723

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

25.112

20.868

14.757

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

136.140

66.461

44.966

 

 

 

 

 

Less

TAX

23.879

21.162

15.062

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

112.261

45.299

29.904

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

1894.359

0.000

0.000

 

TOTAL EARNINGS

1894.359

0.000

0.000

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

995.807

0.000

0.000

 

TOTAL IMPORTS

995.807

0.000

0.000

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

15.86

7.24

5.07

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

0.000

0.000

0.000

Net cash flows from (used in) operations

343.374

25.883

29.958

Net cash flows from (used in) operating activities

319.494

8.247

18.612

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

[Sundry Debtors / Income * 365]

44.47

117.06

94.40

 

 

 

 

Account Receivables Turnover

[Income / Sunday Debtors]

8.21

3.12

3.87

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

91.56

113.45

90.18

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.24

1.72

1.34

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.51

0.39

0.32

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.65

0.68

0.68

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.42

0.60

1.03

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

1.71

1.93

1.79

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.84

0.94

1.29

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

6.91

6.25

5.64

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

PAT to Sales

((PAT / Sales) * 100)

%

4.23

2.94

2.76

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

8.76

4.91

4.57

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

25.31

16.12

16.89

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

1.19

1.22

1.34

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.99

1.10

1.17

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.35

0.30

0.27

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

2.43

2.40

3.08

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.19

1.22

1.34

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts


 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Share Capital

58.917

70.640

76.928

Reserves & Surplus

118.173

210.362

366.638

Net worth

177.090

281.002

443.566

 

 

 

 

Long Term borrowings

125.173

86.541

70.686

Short Term borrowings

56.358

83.168

116.386

Current Maturities of Long term debt

0.000

0.000

0.000

Total borrowings

181.531

169.709

187.072

Debt/Equity ratio

1.025

0.604

0.422

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Sales

1085.003

1541.081

2651.244

 

 

42.035

72.038

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Sales

1085.003

1541.081

2651.244

Profit

29.904

45.299

112.261

 

2.76%

2.94%

4.23%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

STATEMENT REGARDING THE STATE OF AFFAIRS OF THE COMPANY: [As On 31.03.2016]

 

The Company has been incorporated with the Main objective of carrying on the business to of manufacture, buy, sell, import, export and generally deal in all types of chemicals, pharmaceuticals, drugs and intermediaries and to carry on the business of consulting engineers in chemicals, pharmaceuticals, and drug industries. During the year, there have been no significant event occur during the period which affect the financial position of the Company. The Company has earned a profit of INR 112.261 million over the previous year revenue of INR 45.199 million. The affairs of the Company are conducted in accordance with the accepted business practices and within the purview of the applicable legislations.

 

 

UNSECURED LOANS:

 

Particulars

31.03.2016

INR In Million

31.03.2015

INR In Million

LONG-TERM BORROWINGS

 

 

Loans and advances from related parties

17.418

23.517

Total

17.418

23.517

 

 

INDEX OF CHARGE:

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

G68543131

100137188

HDFC BANK LIMITED

16/09/2017

-

-

250000000.0

HDFC BANK HOUSE SENAPATI BAPAT MARG, LOWER PAREL (WEST), MUMBAI – 400013, MAHARASHTRA, INDIA

2

G33282005

10577123

ICICI BANK LIMITED

25/06/2015

27/10/2016

-

230000000.0

ICICI BANK TOWER, NEAR CHAKLI CIRCLE, OLD PADRA ROAD, VADODARA – 390007, GUJARAT, INDIA

3

G35135227

10461563

AXIS BANK LIMITED

08/11/2013

31/12/2016

-

307200000.0

1 ST FLOOR,G.PULLAREDDY BUILDING6-3-879/B,GREEN LANDS, BEGUMPET, HYDERABAD – 500016, TELANGANA, INDIA

4

G53420881

10604214

RELIANCE CAPITAL LIMITED

30/10/2015

-

19/09/2017

6972000.0

"H" BLOCK 1ST FLOOR, DHIRUBHAI AMBANI KNOWLEDGE CITY, KOPARKHAIRNE NAVI MUMBAI – 400710, MAHARASHTRA, INDIA

5

G53220562

10542994

RELIANCE CAPITAL LIMITED

31/12/2014

-

22/08/2017

11010552.0

"H" BLOCK 1ST FLOORD, HIRUBHAI AMBANI KNOWLEDGE CITY, KOPARKHAIRNE, NAVI MUMBAI – 400710, MAHARASHTRA, INDIA

6

C66818253

10314834

STANDARD CHARTERED BANK

12/10/2011

19/10/2012

09/10/2015

115000000.0

DOOR NO. 8-2-293/82/A/646A, GR FLOOR, ADITYARAM SQUARE, ROAD NO. 36, JUBILEE HILLS, HYDERABAD – 500003, TELANGANA, INDIA

7

C66818170

10305668

STANDARD CHARTERED BANK

15/07/2011

25/01/2014

09/10/2015

115000000.0

DOOR NO.8-2-293/82/A/646A,GR FLOOR, ADITYARAM SQUARE, ROAD NO. 36, JUBILEE HILLS, HYDERABAD – 500003, TELANGANA, INDIA

8

B92152594

10027065

SMALL INDUSTRIES DEVELOPEMENT BANK OF INDIA

24/11/2006

29/04/2013

16/12/2013

68005000.0

101 IST FLOOR HERMITAGE COMPLEX, SAIFABAD, HYDERABAD – 500004, TELANGANA, INDIA

 

 

FIXED ASSETS:

 

Tangible Assets

 

·         Factory Land

·         Factory Building

·         Pollution Control Plant

·         Lab Equipment

·         Plant and Machinery

·         Furniture and Fixtures

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.37

UK Pound

1

INR 78.89

Euro

1

INR 89.71

 

 

INFORMATION DETAILS

 

Analysis Done by :

VVK

 

 

Report Prepared by :

GEET

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.